natgillin/translations-raw huggingface dataset:
Superior efficacy has been demonstrated with the combination of pegylated interferon with ribavirin (sustained response rate of 61 % achieved in a study performed in naïve patients with a ribavirin dose > 10.6 mg/kg, p < 0.01). 
Boljša učinkovitost pa se je pokazala pri uporabi pegiliranega interferona z ribavirinom (v študiji, opravljeni pri bolnikih, ki še niso prejemali tega zdravila, je bil z uporabo ribavirina v odmerku > 10,6 mg/kg, p < 0,01 61 % dosežen trajen virološki odziv na zdravljenje).
Adult patients: Viraferon alone or in combination with ribavirin has been studied in 4 randomised Phase III clinical trials in 2,552 interferon-naïve patients with chronic hepatitis C. The trials compared the efficacy of Viraferon used alone or in combination with ribavirin. 
Odrasli bolniki: Zdravilo Viraferon v monoterapiji ali v kombinaciji z ribavirinom so raziskovali v 4 randomiziranih kliničnih raziskavah tretje faze pri 2.552 bolnikih, ki še niso bili zdravljeni z interferonom in so imeli kronični hepatitis C. V teh raziskavah so primerjali učinkovitost zdravila Viraferon v monoterapiji ali v kombinaciji z ribavirinom.
Cardiovascular (CVS) adverse events, particularly arrhythmia, appeared to be correlated mostly with preexisting CVS disease and prior therapy with cardiotoxic agents (see section 4.4). 
Videti je bilo, da kardiovaskularni (KVS) neželeni pojavi, še posebej aritmija, statistično korelirajo predvsem z obstoječo KVS boleznijo in predhodno terapijo s kardiotoksičnimi snovmi (glejte poglavje 4.4).
A general reversal of these trends was noted during the 6 months follow-up post treatment. 
V času 6-mesečnega spremljanja po zdravljenju so opazili splošni obrat teh trendov.
Dispose of the syringe and needle safely in a closed container. 
Brizgo in iglo zavrzite varno, v zaprti posodi.
The push button scale will show you the dose set (see Diagram N below). 
Na lestvici pritisnega gumba je viden nastavljeni odmerek (glejte sliko N spodaj).
The development of auto-antibodies and autoimmune disorders has been reported during treatment with alpha interferons. 
Poročali so o pojavu avtoprotiteles in avtoimunskih bolezni med zdravljenjem z alfa interferoni.
Some children have had a decrease in their rate of growth (height and weight). 
Pri nekaterih otrocih se je upočasnila rast (telesna višina in masa)
Treatment should be discontinued in case of severe leukopaenia (< 1,200/mm3), severe neutropaenia (< 750/mm3) or severe thrombocytopaenia (< 70,000/mm3). 
Zdravljenje ukinite v primeru hude levkopenije (< 1.200/mm3), hude nevtropenije (< 750/mm3) ali hude trombocitopenije (< 70.000/mm3).
This must be considered during concomitant therapy with medicinal products metabolised by this route, such as the xanthine derivatives theophylline or aminophylline. 
Interferoni lahko vplivajo na oksidativne presnovne procese, kar morate upoštevati med sočasno terapijo z zdravili, ki se presnovijo po tej poti, npr. s ksantinskima derivatoma teofilinom in aminofilinom.
If the product is not used during this four-week period, it should be discarded. 
Če zdravila v teh 4 tednih ne uporabite, ga morate zavreči.
Table 3 Sustained virologic response rates with Viraferon + ribavirin (one year of treatment) by genotype and viral load 
Preglednica 3: Pogostnosti ohranjenega virološkega odziva pri uporabi zdravila Viraferon in ribavirina (enoletno zdravljenje) glede na genotip in virusno obremenitev
To prepare the Viraferon solution insert the needle through the rubber top of the Viraferon vial and gently place the needle tip against the glass wall of the vial without touching the cleaned top of the vial with your hands. 
Za pripravo raztopine zdravila Viraferon vbodite iglo skozi gumijasti vrh viale z zdravilom Viraferon in previdno naslonite vrh igle na stekleno steno viale, ne da bi se pri tem z rokami dotaknili očiščenega vrha viale.
As in adult patients, children and adolescents experienced other psychiatric adverse events (e.g., depression, emotional lability, and somnolence). 
Tako kot pri odraslih bolnikih so tudi pri otroci in mladostniki opazili druge psihiatrične neželene dogodke (npr. depresijo, čustveno labilnost in zaspanost).
At the beginning of treatment with Viraferon, you may experience a flu-like reaction, with fever, fatigue, headache, muscle ache, joint pain and chills/rigors. 
Na začetku zdravljenja z zdravilom Viraferon boste lahko imeli gripi podobno reakcijo z zvišano telesno temperaturo, utrujenostjo, glavobolom, mišičnimi bolečinami, bolečinami v sklepih in mrzlico ali tresenjem.
A new injection needle must be used for each dose. 
Za vsak odmerek morate uporabiti novo injekcijsko iglo.
Remove the needle guard without touching the needle and keep the syringe with the needle in your hand. 
Snemite zaščitni pokrovček igle, ne da bi se dotaknili igle, in držite brizgo z iglo trdno v rokah.
Viraferon 3 MIU/m 
Viraferon (3 m.i.e.
Chronic Hepatitis B: The recommended dosage is in the range 5 to 10 million IU administered subcutaneously three times a week (every other day) for a period of 4 to 6 months. 
Kronični hepatitis B: Priporočeni odmerek je v razponu od 5 do 10 milijonov i.e., injiciran subkutano trikrat na teden (vsak drugi dan) v času 4 do 6 mesecev.
Sufficient needles and swabs are provided to use the Viraferon pen for administering the smallest measurable doses. 
V pakiranju je dovolj igel in tamponov, da si lahko z uporabo peresnika Viraferon bolnik da tudi najmanjše še merljive odmerke.
However, the chemical and physical in-use stability has been demonstrated for 24 hours at 25ºC. 
Vseeno je zdravilo med uporabo kemično in fizikalno stabilno 24 ur pri temperaturi 25 ºC.
Pack of 12 vials 
Pakiranje: 12 vial
Children and adolescents: Multiple-dose pharmacokinetic properties for Viraferon injection and ribavirin capsules in children and adolescents with chronic hepatitis C, between 5 and 16 years of age, are summarized in Table 6. 
Otroci in mladostniki: Farmakokinetične lastnosti pri dajanju večih odmerkov zdravila Viraferon injekcije in ribavirin kapsule pri otrocih in mladostnikih s kroničnim hepatitisom C v starosti od 5 do 16 let so povzete v Preglednici 6.
Although not all of these side effects may occur, they may need medical attention if they do. 
Ni nujno, da se bodo pojavili vsi navedeni neželeni učinki, če pa se, bo zaradi njih lahko potreben obisk pri zdravniku.
Insert the needle into the vial containing the Viraferon solution and inject air into the vial. 
Vstavite iglo v vialo z raztopino zdravila Viraferon in injicirajte zrak v vialo.
If ALT flares during Viraferon therapy to greater than or equal to 2 times baseline, Viraferon therapy may be continued unless signs and symptoms of liver failure are observed. 
Tudi če se med terapijo z zdravilom Viraferon naglo povečajo vrednosti ALT na 2-kratno začetno vrednost ali celo več, lahko terapijo z zdravilom Viraferon nadaljujete, razen če opažate simptome in znake jetrne odpovedi.
The reconstituted solutions are isotonic for parenteral administration. 
Rekonstituirane raztopine so izotonične za parenteralno uporabo.
Patients with existence of or history of severe psychiatric conditions: 
Bolniki s hudimi psihiatričnimi motnjami v sedanji ali pretekli anamnezi:
Chronic Hepatitis C: 
Kronični hepatitis C:
Discontinuation of Viraferon therapy has not reversed thyroid dysfunction occurring during treatment (also see Children and adolescents, Thyroid monitoring). 
Motnje delovanja žleze ščitnice, ki so se pojavile med terapijo z zdravilom Viraferon, niso minile ob prekinitvi terapije (glejte tudi Otroci in mladostniki, Spremljanje delovanja ščitnice).
Completely unscrew the injection needle assembly using an anti-clockwise turning motion as shown in Diagram R. Then carefully lift it off the pen and discard the capped injection needle (see Diagram S). 
Do konca odvijte sklop injekcijske igle, nasprotno smeri urnega kazalca, kot je prikazano na sliki R. Potem ga previdno dvignite s peresnika in zavrzite pokrito injekcijsko iglo (glejte sliko S).
Viraferon, solution for injection, multidose pen is injected subcutaneously after attaching an injection needle and dialing the prescribed dose. 
Viraferon, raztopina za injiciranje v večodmernem peresniku, se injicira subkutano po pritrditvi injekcijske igle in nastavitvi predpisanega odmerka.
if you have a history of seizures (convulsions). 
- če ste imeli kdaj v preteklosti epileptične napade (konvulzije).
Despite this, when medicinal products prepared from human blood or plasma are administered, the possibility of transmitting infective agents cannot be totally excluded. 
Kljub temu pa pri dajanju zdravil, izdelanih iz človeške krvi ali plazme, ni mogoče popolnoma izključiti možnosti za prenos povzročiteljev infekcijskih bolezni.
Keeping the pen pointing upwards, press the push button up fully and see if a drop of Viraferon, solution for injection, appears at the injection needle tip (Notice the drop at the tip of injection needle in Diagram K below). 
Pritisnite na gumb do konca in poglejte, ali se na vrhu injekcijske igle pojavi kapljica Viraferon raztopine za injiciranje (glejte kapljico na vrhu injekcijske igle na sliki K spodaj).
Proper precautions should be taken during reconstitution to prevent microbial contamination (refer to package leaflet). 
Med rekonstitucijo je potrebno upoštevati določene ukrepe za preprečevanje okužb (nanaša se na navodilo za uporabo).
In combination therapy with ribavirin, take notice of the respective informing texts of ribavirin containing medicinal products. 
V primeru kombinirane terapije z ribavirinom morate upoštevati tudi ustrezne informacije o zdravilu, ki vsebuje ribavirin.
HCV/HIV Co-infected patients 
Bolniki, sočasno okuženi z virusoma HCV in HIV
Arthralgia, myalgia, musculoskeletal pain 
artralgija, mialgija, mišičnoskeletne bolečine
If the product is not reconstituted during the four-week period, it cannot be put back in the refrigerator for a new storage period and must be discarded. 
Če zdravilo v času 4 tednov ni rekonstituirano, ga ne smete dati nazaj v hladilnik za naslednje 4 tedne, ampak ga morate zavreči.
Adults: The efficacy of Viraferon is enhanced when given in combination with ribavirin. 
Odrasli: Učinkovitost zdravila Viraferon je večja, če ga uporabljate v kombinaciji z ribavirinom.
After withdrawal of the dose, any remaining solution must be discarded. 
Po odvzemu odmerka iz viale morate vso preostalo raztopino zavreči.
Ribavirin 15 mg/kg/day as 2 divided doses 
Ribavirin 15 mg/kg na dan v obliki 2 deljenih odmerkov
Clinically significant laboratory abnormalities, most frequently occurring at doses greater than 10 million IU daily, include reduction in granulocyte and white blood cell counts; decreases in haemoglobin level and platelet count; increases in alkaline phosphatase, LDH, serum creatinine and serum urea nitrogen levels. 
Med klinično pomembna odstopanja laboratorijskih vrednosti, ki se najpogosteje pojavijo pri odmerkih, večjih od 10 milijonov i.e. na dan, sodijo zmanjšanje števila granulocitov in levkocitov, zmanjšanje vrednosti hemoglobina in števila trombocitov, povečanje vrednosti alkalne fosfataze, LDH, serumskega kreatinina in dušičnih retentov iz sečnine v serumu.
Measuring the dose of Viraferon 
Merjenje odmerka zdravila Viraferon
Tap the top of the ampoule of solvent gently to make sure that all the liquid is at the bottom of the ampoule. 
Nežno potrkajte po vrhu ampule s topilom, da bo vsa tekočina stekla na dno ampule.
Use a new injection needle for each dose. 
Za vsak odmerek uporabite novo injekcijsko iglo.
Remove the pen from the refrigerator approximately 30 minutes before administration to allow the injectable solution to reach room temperature (not more than 25°C). 
Peresnik vzemite iz hladilnika približno 30 minut pred uporabo, da se bo raztopina za injiciranje lahko segrela na sobno temperaturo (na največ 25 C).
The mean serum interferon concentrations following subcutaneous and intramuscular injections were comparable. 
Srednja serumska koncentracija interferona po subkutanem injiciranju je bila podobna tisti po intravenskem injiciranju.
Periodontal (affecting gums) and dental disorders, altered mental status, loss of consciousness, acute hypersensitivity reactions including urticaria (hives), angioedema (swelling of the hands, feet, ankles, face, lips, mouth, or throat which may cause difficulty in swallowing or breathing), bronchoconstriction and anaphylaxis (a severe, whole-body allergic reaction) have been reported, but their frequency is unknown. 
Poročali so tudi o periodontalni bolezni (prizadetost dlesni), zobnih boleznih, spremenjenem duševnem stanju, izgubi zavesti ter akutnih preobčutljivostnih reakcijah, vključno z urtikarijo (koprivnica), angioedemom (otekanje dlani, stopal, gležnjev, obraza, ustnic, ust ali žrela, ki lahko povzroči težave pri požiranju ali dihanju), bronhokonstrikcijo in anafilaksijo (huda alergijska reakcija po vsem telesu), vendar njihova pogostnost ni znana.
METHOD AND ROUTE(S) OF ADMINISTRATION Subcutaneous use. 
POSTOPEK IN POT(I) UPORABE ZDRAVILA Subkutana uporaba
However, as for any pharmacologically active compound, symptomatic treatment with frequent monitoring of vital signs and close observation of the patient is indicated. 
Ni poročil o primerih prevelikega odmerjanja, ki bi vodil do akutnih kliničnih pojavov, vendar je kot pri vsaki farmakološko aktivni spojini indicirano simptomatsko zdravljenje s pogostim spremljanjem vitalnih znakov in natančnim opazovanjem bolnika.
HOW TO SELF INJECT VIRAFERON 
KAKO SI SAMI INJICIRATE ZDRAVILO VIRAFERON
An improvement in liver histology has been observed. 
Opažali so tudi izboljšanje histološkega izvida jeter.
Your doctor may recommend that you take paracetamol if you develop these symptoms. 
Če se pojavijo ti simptomi, vam bo vaš zdravnik lahko priporočil jemanje paracetamola.
Examine the solution prior to administration: it should be clear and colourless. 
Preglejte raztopino pred uporabo: biti mora bistra in brezbarvna.
Due to the lack of data in children with severe progression of the disease, and the potential for undesirable effects, the benefit/risk of the combination of ribavirin and interferon alfa-2b needs to be carefully considered in this population (see sections 4.1, 4.4 and 4.8). 
Zaradi pomanjkanja podatkov pri otrocih s hudim napredovanjem bolezni in možnostjo pojava neželenih učinkov je potrebno pred uporabo kombinacije ribavirina in interferona alfa-2b v tej populaciji skrbno pretehtati razmerje med koristnostjo zdravljenja in tveganjem.
Preparation Collect necessary items before you begin: the Viraferon multidose pen; a needle for subcutaneous injection (provided in the packaging); a cleansing swab. 
Preden začnete, si pripravite vse potrebne pripomočke: - večodmerni peresnik zdravila Viraferon; - iglo za subkutano injiciranje (priložena v pakiranju); - čistilni tampon.
A wide variety of autoimmune and immune-mediated disorders have been reported with alpha interferons including thyroid disorders, systemic lupus erythematosus, rheumatoid arthritis (new or aggravated), idiopathic and thrombotic thrombocytopenic purpura, vasculitis, neuropathies including mononeuropathies (see also section 4.4). 
Pri uporabi alfa interferonov so poročali o širokem razponu avtoimunskih in imunsko odvisnih motenj, npr. motnjah delovanja žleze ščitnice, sistemski lupus eritematosus, reumatoidni arthritis (novonastali ali že poslabšan), idiopatski in trombotični trombocitopenični purpuri, vaskulitisu ter nevropatijah, vključno z mononevropatijami (glejte tudi poglavje 4.4).
The following instructions explain how to inject Viraferon yourself. 
V teh navodilih je opisano, kako si lahko sami injicirate zdravilo Viraferon.
Psychiatric disorders Very common: 
Psihiatrične motnje§ Zelo pogosti:
The dosage will vary according to the disease being treated. 
Odmerki zdravila Viraferon se razlikujejo med bolniki, glede na bolezen, ki jo zdravimo.
Genotype 2, 
Genotipa 1, Genotipa 2,
Now screw the injection needle onto the pen securely by turning it in a clockwise direction (see Diagram F). 
Trdno privijte injekcijsko iglo na peresnik tako, da jo obračate v smeri urnega kazalca (glejte sliko F).
Prior to initiation of Viraferon therapy, TSH levels must be evaluated and any thyroid abnormality detected at that time must be treated with conventional therapy. 
Pred uvedbo terapije z zdravilom Viraferon morate ovrednotiti vrednost TSH in morebitne motnje v delovanju ščitnice, ki jih ugotovite v tem času, zdraviti z ustaljeno terapijo.
Detailed instructions for subcutaneous administration are provided with this leaflet (see HOW TO SELF INJECT VIRAFERON at the end of the leaflet). 
Podrobna navodila za podkožno injiciranje so priložena temu navodilu (glejte poglavje KAKO SI SAMI INJICIRATE ZDRAVILO VIRAFERON - na koncu navodil).
Diagram Q 
Slika Q
While being treated with Viraferon, your doctor may want you to drink extra fluids to help prevent low blood pressure. 
Uporaba zdravila Viraferon skupaj s hrano in pijačo Medtem, ko prejemate zdravilo Viraferon vam bo vaš zdravnik lahko naročil, naj pijete več tekočine, da bi preprečili nizek krvni tlak.
Viraferon may be administered using either glass or plastic disposable injection syringes. 
Zdravilo Viraferon lahko injicirate s steklenimi ali plastičnimi brizgami za enkratno uporabo.
To dissolve the white contents, swirl the Viraferon vial with a gentle rotary motion leaving the syringe needle in the vial, until the contents are completely dissolved. 
Da se bo bela vsebina viale zdravila Viraferon raztopila, le-to nežno obračajte, pri čemer naj igla z brizgo ostane v viali, dokler se vsebina viale popolnoma ne raztopi.
Among children and adolescents treated with Viraferon in combination with ribavirin, suicidal ideation or attempts were reported more frequently compared to adult patients (2.4 % vs 1 %) during treatment and during the 6-month follow-up after treatment. 
Pri otrocih in mladostnikih so pogosteje poročali o samomorilnih mislih ali poskusu samomora kot pri odraslih (2,4 % v primerjavi z 1 %) med zdravljenjem in v času 6-mesečnega spremljanja bolnikov po zdravljenju.
In clinical trials using Viraferon therapy, 2.8 % patients overall developed thyroid abnormalities. 
V kliničnih raziskavah terapije z zdravilom Viraferon so se pri 2,8 % vseh bolnikov pojavile ščitnične motnje.
Response rates in these trials were increased with compliance. 
Pogostnosti odziva v teh raziskavah so se povečevale z boljšim sodelovanje bolnika.
Females of childbearing potential and their partners must each use an effective contraceptive during treatment and for 4 months after treatment has been concluded. 
Tako ženske v rodni dobi kot njihovi partnerji morajo uporabljati učinkovito kontracepcijo med zdravljenjem in še 4 mesece po zaključku zdravljenja.
Clear and colourless solvent. 
Bister in brezbarven vehikel.
Based on the results of clinical trials, in which data are available for 12 months of treatment, it is recommended that patients be treated with Viraferon in combination with ribavirin for at least 6 months. 
Na podlagi poročil iz kliničnih raziskav, v katerih so navedeni podatki za 12-mesečno zdravljenje, priporočamo, da te bolnike zdravite najmanj 6 mesecev z zdravilom Viraferon v kombinaciji z ribavirinom.
If the product is not used during the seven-day period, it should be discarded. 
Če zdravila v teh 7 dneh ne uporabite, ga morate zavreči.
You and your partner must each use an effective contraceptive during the time you are taking ribavirin and for 4 months after stopping treatment. 
Tako vi kot vaš partner morata uporabljati učinkovito kontracepcijo v času jemanja ribavirina in še 4 mesece po zaključku zdravljenja.
Other negative prognostic factors (age > 40 years, male gender, bridging fibrosis) should be taken into account in order to extend therapy to 12 months. 
Pri odločitvi o podaljšanju terapije na 12 mesecev upoštevajte tudi druge negativne prognostične dejavnike (starost > 40 let, moški spol, premostitvena fibroza).
The pharmacokinetics of Viraferon were studied in healthy volunteers following single 5 million IU/m2 and 10 million IU doses administered subcutaneously, at 5 million IU/m administered intramuscularly and as a 
Farmakokinetiko zdravila Viraferon so raziskovali pri zdravih prostovoljcih po enkratnih subkutanih odmerkih po 5 milijonov i.e./m2 in 10 milijonov i.e., po intramuskularnem dajanju 5 milijonov i.e./m2 in po 30-minutni intravenski infuziji.
The abnormalities were controlled by conventional therapy for thyroid dysfunction. 
Te so lahko nadzorovali s konvencionalno terapijo motenj delovanja ščitnice.
Take the pen out of the refrigerator about one-half hour before administering the dose so that the solution in the pen is at room temperature when it is injected. 
Peresnik vzemite iz hladilnika približno pol ure pred injiciranjem, da bo raztopina v njem ob injiciranju na sobni temperaturi.
Extreme care must be taken to avoid pregnancy in female patients or in partners of male patients taking Viraferon in combination with ribavirin. 
Zdravljenje z ribavirinom je kontraindicirano pri nosečnicah, zato je potrebna posebna previdnost v izogib nosečnosti pri bolnicah ter tudi pri partnerkah bolnikov, ki jemljejo zdravilo Viraferon v kombinaciji z ribavirinom.
If you are a male patient, you and your partner must each use an effective contraceptive during the time you are taking ribavirin and for 7 months after stopping treatment. 
Če ste moški, morata tako vi kot vaša partnerka uporabljati učinkovito kontracepcijsko sredstvo v času jemanja ribavirina in še 7 mesecev po zaključku zdravljenja.
Based on the results of clinical trials, in which data are available for 6 months of treatment, it is recommended that patients be treated with Viraferon in combination with ribavirin for 6 months. 
Na podlagi poročil iz kliničnih raziskav, v katerih so navedeni podatki za 6-mesečno zdravljenje, priporočamo, da te bolnike zdravite 6 mesecev z zdravilom Viraferon v kombinaciji z ribavirinom.
Psychiatric disorders 
Psihiatrične motnje§
If you are receiving HAART, the addition of Viraferon and ribavirin may increase your risk of lactic acidosis and of liver failure. 
Če prejemate HAART, lahko dodatek zdravila Viraferon z ribavirinom tej terapiji poveča tveganje za nastanek laktoacidoze in jetrne odpovedi.
Change your injection site each time. 
Pri vsakem injiciranju menjavajte injekcijsko mesto.
Additionally, Vogt-Koyanagi-Harada syndrome (an autoimmune inflammatory disorder affecting the eyes, skin and the membranes of the ears, brain and spinal cord) has been reported with Viraferon use. 
Poleg tega so pri uporabi zdravila Viraferon poročali tudi o pojavu sindroma Vogt-Koyanagi-Harada (avtoimunska vnetna bolezen, ki prizadene oči, kožo in ušesne membrane ter ovojnice možgan in hrbtenjače).
12 multiple dose vials 
12 vial z večkratnimi odmerki
Viraferon was administered at a dose of 3 MIU 3 times a week as monotherapy or in combination with ribavirin. 
Zdravilo Viraferon so dajali bolnikom v odmerku 3 mio i.e. trikrat na teden, v monoterapiji ali v kombinaciji z ribavirinom.
Viraferon is presented as a solution for injection 
Viraferon je na voljo kot raztopina za injiciranje
Co-infected patients with advanced cirrhosis receiving HAART may be at increased risk of hepatic decompensation and death. 
Pri bolnikih, ki so okuženi tudi z virusom HIV in imajo napredovano cirozo ter prejemajo terapijo HAART, je lahko povečano tveganje za jetrno dekompenzacijo in smrt.
Hold the Viraferon vial upright without touching the cleaned top of the vial with your hands. 
Držite vialo zdravila Viraferon pokončno, ne da bi se pri tem z rokami dotaknili očiščenega vrha viale.
No studies have been conducted in juvenile animals to examine the effects of treatment with interferon alfa2b on growth, development, sexual maturation, and behaviour ((see section 4.4 and Rebetol SPC if Viraferon is to be administered in combination with ribavirin). 
Študije za proučevanje učinkov zdravljenja z interferonom alfa-2b na rast, razvoj, spolno zorenje in vedenje živali niso bile opravljene pri mladih živalih (če boste zdravilo Viraferon uporabljali v kombinaciji z ribavirinom, glejte poglavje 4.4 in SPC za zdravilo Rebetol).